Cambridge Investment Research Advisors, Inc. Senseonics Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 346,356 shares of SENS stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
346,356
Previous 289,919
19.47%
Holding current value
$2.5 Million
Previous $190,000
13.16%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SENS
# of Institutions
154Shares Held
145MCall Options Held
588KPut Options Held
299K-
First Light Asset Management, LLC Edina, MN35.7MShares$257 Million2.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$241 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.7MShares$62.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$60 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL7.92MShares$57.1 Million0.06% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $3.36B
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...